| Application no. and date | 15732554.9 (espacenet) (Federated) (European Patent Register), 20150608 | | Patent/reg. no. and date | DK/EP 3152230, 20190807 | | Publication date | 20170412 | | Priority no. and date | EP 14171579, 20140606 | | EP pub. no. and date |
EP 3152230 20170412 | | Effective date | | | Applicant/owner | Octapharma AG, Seidenstrasse 2
8853 Lachen, CH | | Applicant ref. no. | PV1937DKEP | | Inventor | KANNICHT, Christoph, Dieffenbachstrasse 33
10967 Berlin, DE,
SOLECKA, Barbara, Beymestrasse 13
12167 Berlin, DE,
KOHLA, Guido, Helene von Mülinenweg 44
12205 Berlin, DE,
WINGE, Stefan, LÃ¥nghalsvägen 17 2tr
12050 ÿrsta, SE | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/36 (2006.01) , A61K 38/37 (2006.01) , A61P 7/04 (2006.01) , C07K 14/755 (2006.01) | | Title | PRÆPARAT OMFATTENDE FAKTOR VIII OG VON WILLEBRAND-FAKTOR-PEPTIDER | | Int. application no. | EP2015062730 | | Int. publication no. | WO2015185758 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
